
Weight Management
A GLP-1 receptor agonist, one of the most widely researched peptides for weight management.
READ THE RESEARCH
STEP 1 trial (New England Journal of Medicine): once-weekly semaglutide in adults with overweight or obesity — average 14.9% body-weight reduction.
SIZE
For laboratory research use only. Not for human consumption. Not intended to diagnose, treat, cure or prevent any disease.